147 related articles for article (PubMed ID: 26659720)
1. Increased expression of ERCC2 gene in head and neck cancer is associated with aggressive tumors: a systematic review and case-control study.
Zafeer M; Mahjabeen I; Kayani MA
Int J Biol Markers; 2016 Feb; 31(1):e17-25. PubMed ID: 26659720
[TBL] [Abstract][Full Text] [Related]
2. Expression of PTEN and its correlation with proliferation marker Ki-67 in head and neck cancer.
Ahmed MW; Kayani MA; Shabbir G; Ali SM; Shinwari WU; Mahjabeen I
Int J Biol Markers; 2016 May; 31(2):e193-203. PubMed ID: 26916897
[TBL] [Abstract][Full Text] [Related]
3. ERCC1 and ERCC2 as predictive biomarkers to oxaliplatin-based chemotherapy in colorectal cancer patients from Egypt.
Kassem AB; Salem SE; Abdelrahim ME; Said AS; Salahuddin A; Hussein MM; Bahnassy AA
Exp Mol Pathol; 2017 Feb; 102(1):78-85. PubMed ID: 28088319
[TBL] [Abstract][Full Text] [Related]
4. Decreased mRNA expression levels of base excision repair (BER) pathway genes is associated with enhanced Ki-67 expression in HNSCC.
Mahjabeen I; Chen Z; Zhou X; Kayani MA
Med Oncol; 2012 Dec; 29(5):3620-5. PubMed ID: 22798271
[TBL] [Abstract][Full Text] [Related]
5. DNA repair gene polymorphisms and risk of head and neck cancer in the Tunisian population.
Khlifi R; Kallel I; Hammami B; Hamza-Chaffai A; Rebai A
J Oral Pathol Med; 2014 Mar; 43(3):217-24. PubMed ID: 24020925
[TBL] [Abstract][Full Text] [Related]
6. Xeroderma pigmentosum, complementation group D expression in H1299 lung cancer cells following benzo[a]pyrene exposure as well as in head and neck cancer patients.
Lin CS; Chiou WY; Lee KW; Chen TF; Lin YJ; Huang JL
J Toxicol Environ Health A; 2016; 79(1):39-47. PubMed ID: 26731659
[TBL] [Abstract][Full Text] [Related]
7. Effects of ERCC2 Lys751Gln (A35931C) and CCND1 (G870A) polymorphism on outcome of advanced-stage squamous cell carcinoma of the head and neck are treatment dependent.
Zhong S; Nukui T; Buch S; Diergaarde B; Weissfeld LA; Grandis J; Romkes M; Weissfeld JL
Cancer Epidemiol Biomarkers Prev; 2011 Nov; 20(11):2429-37. PubMed ID: 21890746
[TBL] [Abstract][Full Text] [Related]
8. Genotypes and haplotypes of ERCC1 and ERCC2/XPD genes predict levels of benzo[a]pyrene diol epoxide-induced DNA adducts in cultured primary lymphocytes from healthy individuals: a genotype-phenotype correlation analysis.
Zhao H; Wang LE; Li D; Chamberlain RM; Sturgis EM; Wei Q
Carcinogenesis; 2008 Aug; 29(8):1560-6. PubMed ID: 18635523
[TBL] [Abstract][Full Text] [Related]
9. ERCC2/XPD Lys751Gln alter DNA repair efficiency of platinum-induced DNA damage through P53 pathway.
Zhang G; Guan Y; Zhao Y; van der Straaten T; Xiao S; Xue P; Zhu G; Liu Q; Cai Y; Jin C; Yang J; Wu S; Lu X
Chem Biol Interact; 2017 Feb; 263():55-65. PubMed ID: 28027876
[TBL] [Abstract][Full Text] [Related]
10. Single nucleotide polymorphisms and expression of ERCC1 and ERCC2 vis-à-vis chemotherapy drug cytotoxicity in human glioma.
Chen H; Shao C; Shi H; Mu Y; Sai K; Chen Z
J Neurooncol; 2007 May; 82(3):257-62. PubMed ID: 17151930
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of ERCC2, ABCC2 and MMP2 of response and long-term survival in locally advanced head and neck cancer patients treated with chemoradiotherapy.
Duran G; Cruz R; Aguín S; Barros F; Giráldez JM; Bernárdez B; Zarra I; López-López R; Carracedo Á; Lamas MJ
Cancer Chemother Pharmacol; 2021 Nov; 88(5):813-823. PubMed ID: 34309735
[TBL] [Abstract][Full Text] [Related]
12. mRNA expression of RRM1, ERCC1 and ERCC2 is not associated with chemosensitivity to cisplatin, carboplatin and gemcitabine in human lung cancer cell lines.
Shimizu J; Horio Y; Osada H; Hida T; Hasegawa Y; Shimokata K; Takahashi T; Sekido Y; Yatabe Y
Respirology; 2008 Jun; 13(4):510-7. PubMed ID: 18494946
[TBL] [Abstract][Full Text] [Related]
13. Deregulation of base excision repair gene expression and enhanced proliferation in head and neck squamous cell carcinoma.
Mahjabeen I; Ali K; Zhou X; Kayani MA
Tumour Biol; 2014 Jun; 35(6):5971-83. PubMed ID: 24622884
[TBL] [Abstract][Full Text] [Related]
14. DNA repair gene ERCC1 and ERCC2/XPD polymorphisms and risk of squamous cell carcinoma of the head and neck.
Sturgis EM; Dahlstrom KR; Spitz MR; Wei Q
Arch Otolaryngol Head Neck Surg; 2002 Sep; 128(9):1084-8. PubMed ID: 12220217
[TBL] [Abstract][Full Text] [Related]
15. [Expression of DNA excision repair enzymes and lung cancer prognosis].
Lü B; Zhang X; Zhang J; Wang ZY; Hao QL; Zhou M; Zhou YK
Zhonghua Nei Ke Za Zhi; 2004 May; 43(5):349-51. PubMed ID: 15182505
[TBL] [Abstract][Full Text] [Related]
16. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
[TBL] [Abstract][Full Text] [Related]
17. [Expressions of ERCC2 and ERCC4 genes in osteosarcoma and peripheral blood lymphocytes and their clinical significance].
Li X; Guo W; Shen DH; Yang RL; Liu J; Zhao H
Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Oct; 39(5):467-71. PubMed ID: 17940561
[TBL] [Abstract][Full Text] [Related]
18. Genetic and expressional variations of APEX1 are associated with increased risk of head and neck cancer.
Mahjabeen I; Baig RM; Sabir M; Kayani MA
Mutagenesis; 2013 Mar; 28(2):213-8. PubMed ID: 23408843
[TBL] [Abstract][Full Text] [Related]
19. The Involvement of ERCC2/XPD and ERCC6/CSB Wild Type Alleles in Protection Against Aging and Cancer.
Savina NV; Nikitchenko NV; Kuzhir TD; Rolevich AI; Krasny SA; Goncharova RI
Curr Aging Sci; 2018; 11(1):45-54. PubMed ID: 28707579
[TBL] [Abstract][Full Text] [Related]
20. ERCC1 Expression Can Predict Response to Platinum-Based Induction Chemotherapy in Head and Neck Cancer Cases.
Ameri A; Mortazavi N; Khoshbakht Ahmadi H; Novin K
Asian Pac J Cancer Prev; 2016; 17(S3):87-91. PubMed ID: 27165214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
